It's being described as the best weight-loss jab yet -with results that outstrip Wegovy or Mounjaro. But anyone hoping to try ...
Presented by EFPIA By GIEDRĖ PESECKYTĖ with CLAUDIA CHIAPPA and HELEN COLLIS PRESENTED BY View in your browser or listen to audio SNEAK PEEK — Defining unmet medical need is not only ...
Online pharmacies are using a loophole to continue selling cheap weight loss drugs that are modeled on Ozempic and Mounjaro, despite new FDA rules.
I can still fit into my Henne jeans (Nadia Bartel's hugely successful brand), but the food here is too good, the winter brutal and my social life has gone from long walks pounding the Bondi-to-Bronte ...
Our annual healthcare roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.
New guidance from the European Association for the Study of Obesity says that semaglutide or tirzepatide should be first-line ...
People taking semaglutide report far fewer obsessive thoughts about food, with cravings dropping sharply and mental health improving. This new research hints the drug may offer freedom from the ...
Does compounded Semaglutide work for weight loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to understand ...
Half of patients on the weight loss drug semaglutide who do not have diabetes stop taking it within a year. This is the discovery of a population-wide study that looked into adults who started taking ...
Please provide your email address to receive an email when new articles are posted on . HF with preserved ejection fraction is common among people with obesity and type 2 diabetes. New real-world data ...
According to Novo Nordisk, this study was the first to compare these GLP-1 receptor agonists in a real-world setting. Findings from a real-world study evaluating cardiovascular disease-related ...
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the ...